MiMedx Group, Inc. (MDXG)
3.21
-0.03
(-0.93%)
USD |
NASDAQ |
Nov 13, 16:00
3.20
-0.01
(-0.31%)
After-Hours: 19:59
MiMedx Group Price : 3.21 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 3.25 | 3.285 | 3.155 | 3.21 | 1.128M |
| Nov 12, 2026 | 3.30 | 3.335 | 3.205 | 3.24 | 1.475M |
| Nov 11, 2026 | 3.34 | 3.42 | 3.28 | 3.32 | 1.225M |
| Nov 10, 2026 | 3.30 | 3.41 | 3.26 | 3.37 | 1.159M |
| Nov 09, 2026 | 3.31 | 3.37 | 3.220 | 3.32 | 868752.0 |
| Nov 06, 2026 | 3.25 | 3.39 | 3.225 | 3.31 | 1.107M |
| Nov 05, 2026 | 3.20 | 3.29 | 3.05 | 3.28 | 2.833M |
| Nov 04, 2026 | 3.31 | 3.44 | 3.15 | 3.20 | 1.838M |
| Nov 03, 2026 | 3.27 | 3.30 | 3.14 | 3.25 | 1.578M |
| Nov 02, 2026 | 3.88 | 3.88 | 3.27 | 3.28 | 2.562M |
| Oct 30, 2026 | 3.98 | 3.99 | 3.79 | 3.88 | 2.125M |
| Oct 29, 2026 | 3.62 | 4.015 | 3.561 | 3.97 | 4.044M |
| Oct 28, 2026 | 3.88 | 3.995 | 3.87 | 3.95 | 1.263M |
| Oct 27, 2026 | 3.86 | 3.90 | 3.79 | 3.90 | 1.920M |
| Oct 26, 2026 | 3.93 | 3.93 | 3.815 | 3.85 | 1.109M |
| Oct 23, 2026 | 3.90 | 3.93 | 3.85 | 3.91 | 1.263M |
| Oct 22, 2026 | 3.70 | 4.025 | 3.67 | 3.93 | 1.576M |
| Oct 21, 2026 | 4.20 | 4.20 | 3.73 | 3.74 | 2.604M |
| Oct 20, 2026 | 4.40 | 4.46 | 4.21 | 4.23 | 1.633M |
| Oct 19, 2026 | 4.44 | 4.47 | 4.26 | 4.38 | 2.687M |
| Oct 16, 2026 | 4.66 | 4.69 | 4.40 | 4.43 | 2.728M |
| Oct 15, 2026 | 4.76 | 4.875 | 4.655 | 4.68 | 1.331M |
| Oct 14, 2026 | 4.65 | 4.74 | 4.64 | 4.70 | 1.635M |
| Oct 13, 2026 | 4.86 | 4.87 | 4.68 | 4.69 | 972932.0 |
| Oct 12, 2026 | 4.68 | 4.84 | 4.63 | 4.83 | 625570.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 13.40 |
| Perspective Therapeutics, Inc. | 0.9431 |
| T2 Biosystems, Inc. | 0.01 |
| ABVC BioPharma, Inc. | 0.91 |
| Enovis Corp. | 27.68 |
Price Related Metrics
| PS Ratio | 1.565 |
| Price to Book Value | 2.219 |
| Price to Free Cash Flow | 28.31 |
| Earnings Yield | -4.11% |
| Market Cap | 468.42M |